This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Imelda Lanbkin: Innovator in Pharmaceutical Targeting
Introduction
Imelda Lanbkin is a notable inventor based in Ireland, recognized for her contributions to pharmaceutical targeting technologies. With a focus on developing synthetic polypeptide ligands, her work aims to enhance the delivery of pharmaceutical agents to specific intestinal tissues.
Latest Patents
Imelda Lanbkin holds a patent for "PEYERS'S Patch AND/OR M-Celle Targeting Ligands," which involves purified synthetic polypeptide ligands designed for targeting pharmaceutical agents to intestinal epithelial tissue, particularly Peyer's patch and/or M-Cell tissue. This innovation also includes methods for utilizing these ligands effectively.
Career Highlights
Throughout her career, Imelda has worked with prominent companies in the pharmaceutical sector, including Elan Corporation, Plc and Daniel O'Mahony. Her experience in these organizations has contributed significantly to her expertise in the field of pharmaceutical innovations.
Collaborations
Imelda has collaborated with notable individuals such as Daniel O'Mahony and Lisa Higgins, who is a woman. These collaborations have further enriched her work and expanded her impact in the industry.
Conclusion
Imelda Lanbkin's innovative work in pharmaceutical targeting showcases her dedication to advancing medical science. Her contributions, particularly in developing ligands for targeted drug delivery, highlight her role as a significant inventor in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile